JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online September 14, 2007, 10.2967/jnumed.106.039107
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jnumed.106.039107v1
48/10/1670    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Giorgetti, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giorgetti, A.
Journal of Nuclear Medicine Vol. 48 No. 10 1670-1675
© 2007 by Society of Nuclear Medicine

doi: 10.2967/jnumed.106.039107

Clinical Investigation

Feasibility and Diagnostic Accuracy of a Gated SPECT Early-Imaging Protocol: A Multicenter Study of the Myoview Imaging Optimization Group

Assuero Giorgetti, Massimiliano Rossi, Mario Stanislao, Guido Valle, Pietro Bertolaccini, Alberto Maneschi, Raffaele Giubbini, Maria Luisa De Rimini, Marco Mazzanti, Mario Cappagli, Elisa Milan, Duccio Volterrani, Paolo Marzullo and on behalf of the Myoview Imaging Optimization group

CNR Institute of Clinical Physiology, Pisa, Italy

Correspondence: For correspondence or reprints contact: Assuero Giorgetti, MD, CNR Institute of Clinical Physiology, Via Moruzzi 1, 56124, Pisa, Italy. E-mail: asso{at}ifc.cnr.it

The aim of this study was to investigate whether early (time 1, or T1) myocardial tetrofosmin imaging is feasible and as accurate in detecting coronary artery disease as is standard delayed (time 2, or T2) imaging. Methods: One hundred twenty patients (100 men and 20 women; mean age ± SD, 61 ± 10 y) with anginal symptoms underwent tetrofosmin gated SPECT. Stress/rest T1 imaging was performed at 15 min and T2 at 45 min after injection. Image quality was visually evaluated using a 4-point scale (from 0 = poor to 3 = optimal). Myocardial perfusion analysis was performed on a 20-segment model using quantitative perfusion SPECT software, and reversible ischemia was scored as a summed difference score (SDS). Coronary angiography was performed within 1 mo on all patients, and stenosis of more than 50% of the diameter was considered significant. Results: Overall, quality was scored as optimal or good for 94% of T1 images and 95% of T2 images (P = not statistically significant). Heart, lung, liver, and subdiaphragmatic counts did not differ for stress and rest T1 and T2 imaging. A good linear relationship was seen between T1 and T2 SDS (r = 0.69; P < 0.0001), and Bland–Altman analysis showed good agreement between the 2 conditions. In terms of global diagnostic accuracy, areas under the receiver-operating-characteristic curve were comparable between T1 and T2 (0.80 vs. 0.81, P = not statistically significant). Discrepancies between T1 and T2 SDS were observed in 44% of patients (T1 – T2 SDS > 2). Linear regression analysis showed a good correlation between T1 and T2 SDS (r = 0.67; P < 0.0001), whereas the Bland–Altman method showed a shift in the mean value of the difference of +2.67 ± 2.73. In patients with a T1 – T2 SDS of more than 2, areas under the receiver-operating-characteristic curves were significantly higher for T1 than for T2 images (0.79 vs. 0.70, P < 0.001). Conclusion: T1 imaging is feasible and as accurate as T2 imaging in identifying coronary artery disease. However, in a discrete subset of patients, early acquisition strengthens the clinical message of defect reversibility by permitting earlier, more accurate identification of more severe myocardial ischemia.

Key Words: tetrofosmin • gated SPECT • myocardial imaging • early imaging • delayed imaging • coronary artery disease

COPYRIGHT © 2007 by the Society of Nuclear Medicine, Inc.


Related articles in JNM:

This Month in JNM

JNM 2007 48: 11A-12A. [Full Text]  



This article has been cited by other articles:


Home page
JNMHome page
B. A. Herzog, R. R. Buechel, R. Katz, M. Brueckner, L. Husmann, I. A. Burger, A. P. Pazhenkottil, I. Valenta, O. Gaemperli, V. Treyer, et al.
Nuclear Myocardial Perfusion Imaging with a Cadmium-Zinc-Telluride Detector Technique: Optimized Protocol for Scan Time Reduction
J. Nucl. Med., January 1, 2010; 51(1): 46 - 51.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
E. Fommei, L. Bruselli, A. Ripoli, A. Gimelli, S. Ghione, A. Giorgetti, A. Kush, I. D. Tagliavia, C. Passino, and P. Marzullo
Single-Shot Cardiorenal Scintigraphy with 99mTc-Tetrofosmin: A Dynamic Characterization at Rest and During Adenosine Infusion
J. Nucl. Med., August 1, 2009; 50(8): 1288 - 1295.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
I. Ali, T. D. Ruddy, A. Almgrahi, F. G. Anstett, and R. G. Wells
Half-Time SPECT Myocardial Perfusion Imaging with Attenuation Correction
J. Nucl. Med., April 1, 2009; 50(4): 554 - 562.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2007 by the Society of Nuclear Medicine.